|
INN ▲
|
ATC Code ▼
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
PNEUMOCOCCUS, PURIFIED POLYSACCHARIDES ANTIGEN CONJUGATED |
J07AL02 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005451 |
14-02-2022 |
VALID
|
|
CHOLERA, LIVE ATTENUATED |
J07AE02 |
IT
|
I
|
|
|
|
VALID
|
|
NIRSEVIMAB |
J06BD08 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|
|
TIXAGEVIMAB AND CILGAVIMAB |
J06BD03 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005788 |
25-03-2022 |
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005169 |
18-11-2020 |
VALID
|
|
IMMUNOGLOBULINS, NORMAL HUMAN, FOR INTRAVASCULAR ADM. |
J06BA02 |
IT
|
I
|
|
|
|
VALID
|
|
IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASCULAR ADM. |
J06BA01 |
IT
|
I
|
|
|
|
VALID
|
|
LENACAPAVIR |
J05AX31 |
IT
|
I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
BULEVIRTIDE |
J05AX28 |
IT
|
I
|
22-12-2020 |
EMEA/H/C/004854 |
31-07-2020 |
VALID
|
|
BALOXAVIR MARBOXIL |
J05AX25 |
IT
|
Not authorised
|
|
|
|
VALID
|
|
TECOVIRIMAT |
J05AX24 |
IT
|
I
|
28-04-2022 |
EMEA/H/C/005248 |
06-01-2022 |
VALID
|
|
IBALIZUMAB |
J05AX23 |
IT
|
I
|
|
|
|
VALID
|
|
LETERMOVIR |
J05AX18 |
IT
|
I
|
|
EMEA/H/C/004536 |
08-01-2018 |
VALID
|
|
MARIBAVIR |
J05AX10 |
IT
|
I
|
18-08-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MARAVIROC |
J05AX09 |
IT
|
I
|
|
None |
|
VALID
|
|
LYSOZYME |
J05AX02 |
IT
|
II
|
|
None |
|
VALID
|
|
LAMIVUDINE AND DOLUTEGRAVIR |
J05AR25 |
IT
|
I
|
05-06-2020 |
EMEA/H/C/004909 |
30-06-2019 |
VALID
|
|
LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE |
J05AR24 |
IT
|
I
|
24-04-2020 |
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT |
J05AR22 |
IT
|
I
|
|
|
|
VALID
|
|
DOLUTEGRAVIR AND RILPIVIRINE |
J05AR21 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND BICTEGRAVIR |
J05AR20 |
IT
|
Not authorised
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND RILPIVIRINE |
J05AR19 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR AND COBICISTAT |
J05AR18 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE |
J05AR17 |
IT
|
I
|
|
|
|
VALID
|
|
ATAZANAVIR AND COBICISTAT |
J05AR15 |
IT
|
I
|
|
|
|
VALID
|
|
DARUNAVIR AND COBICISTAT |
J05AR14 |
IT
|
Not authorised
|
|
|
|
VALID
|
|
LOPINAVIR AND RITONAVIR |
J05AR10 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL, ELVITEGRAVIR AND COBICISTAT |
J05AR09 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL AND RILPIVIRINE |
J05AR08 |
IT
|
I
|
|
|
|
VALID
|
|
EMTRICITABINE, TENOFOVIR DISOPROXIL AND EFAVIRENZ |
J05AR06 |
IT
|
I
|
|
|
|
VALID
|
|
TENOFOVIR DISOPROXIL AND EMTRICITABINE |
J05AR03 |
IT
|
I
|
|
|
|
VALID
|
|
GLECAPREVIR AND PIBRENTASVIR |
J05AP57 |
IT
|
I
|
|
|
|
VALID
|
|
ELBASVIR AND GRAZOPREVIR |
J05AP54 |
IT
|
I
|
|
|
|
VALID
|
|
OMBITASVIR, PARITAPREVIR AND RITONAVIR |
J05AP53 |
IT
|
I
|
|
|
|
VALID
|
|
SOFOSBUVIR AND LEDIPASVIR |
J05AP51 |
IT
|
I
|
|
|
|
VALID
|
|
DASABUVIR |
J05AP09 |
IT
|
I
|
|
|
|
VALID
|
|
DACLATASVIR |
J05AP07 |
IT
|
I
|
|
|
|
VALID
|
|
BOCEPREVIR |
J05AP03 |
IT
|
Not authorised
|
01-06-2021 |
|
|
VALID
|
|
RIBAVIRIN |
J05AP01 |
IT
|
I
|
|
|
11-02-2002 |
VALID
|
|
CABOTEGRAVIR |
J05AJ04 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/004976 |
17-12-2020 |
VALID
|
|
DOLUTEGRAVIR |
J05AJ03 |
IT
|
I
|
|
|
|
VALID
|
|
RALTEGRAVIR |
J05AJ01 |
IT
|
I
|
05-10-2020 |
|
|
VALID
|
|
OSELTAMIVIR |
J05AH02 |
IT
|
II
|
|
None |
|
VALID
|
|
DORAVIRINE |
J05AG06 |
IT
|
I
|
24-04-2020 |
|
|
VALID
|
|
RILPIVIRINE |
J05AG05 |
IT
|
I
|
|
|
|
VALID
|
|
ETRAVIRINE |
J05AG04 |
IT
|
I
|
|
None |
|
VALID
|
